Abstract
Objective: To investigate the effects of N-acetylcysteine (NAC) when given as an early treatment to critically ill patients on the serum total anti-oxidant potential (TAP) and urine micro-albumin : creatinine (M : Cr) ratio.
Design: Prospective, placebo controlled, double blinded clinical trial.
Setting: General intensive care unit in a teaching hospital.
Patients: Sixty critically ill patients were recruited but ten were withdrawn due to less than 48 h of ICU stay.
Interventions: After envelope randomisation, patients received either NAC (n=23): a bolus of 150 mg/kg in 250 ml of 5 % dextrose followed by a continuous infusion of 12 mg/kg per h in 500 ml of 5 % dextrose over 24 h or, as controls (n= 27), the equal volume of placebo. Treatment lasted for a minimum of 3, up to a maximum of 5, days. Blood and urine samples were collected on admission (0 h) and then 6 hourly up 18 h.
Measurements and results: There was no significant difference between NAC and placebo groups regarding the required length of inotropic support, mechanical ventilation and ICU stay. There was no significant difference in TAP or M : Cr ratio over 18 h or between the groups.
Conclusions: Our results suggest that NAC had no significant effects on the progress of the TAP and the urinary albumin excretion in our patients, which may suggest that NAC at the given dose has no clinical relevance as an early treatment in the critically ill.
Similar content being viewed by others
References
Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638–1652
Knaus WA, Draper EA, Waner DP, Wagner DP, Zimmermann JE (1985) Prognosis in acute organ-system failure. Ann Surg 202: 685–692
Miller SB, Anderson RJ (1986) The kidney in acute respiratory failure. J Crit Care 2: 45
Bone RC (1994) Sepsis and its complications: the clinical problem. Crit Care Med 22: S8-S11
McCord JM, Fridivich I (1969) Superoxide dismutase. An enzymic function for erythrocuperein (hemocuperein). J Biol Chem 224: 6049–6055
Blake DR, Allen RE, Lunec J (1987) Free radicals in biological systems — a review orientated to inflammatory processes. Br Med Bull 43: 371–385
Gallin JI (1980) Degranulating stimuli decrease the negative surface charge and increase the adhesiveness of human neutrophils. J Clin Invest 65: 298–306
Goode HF, Webster NR (1992) Free radicals and trace element metabolism in sepsis and injury. Br J Intensive Care 2: 312–322
Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK (1996) Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 24: 1179–1183
Bernard GR (1991) N-Acetylcysteine in experimental and clinical acute lung injury. Am J Med 91: 54s-59s
Suter PM, Dominghetti G, Schaller M-D, Laverriere M-C, Ritz R, Perret C (1994) N-Acetylcysteine enhances recovery from acute lung injury in man. Chest 105:190–194
Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, Schaffartzik W (1994) Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med 22:1738–1746
Gosling P, Shearman CP (1988) Increased levels of urinary proteins: markers of vascular permeability? Ann Clin Biochem 25:150–151
Shearman CP, Gosling P, Simms MH (1988) Glomerular permeability to large molecules: a marker of vascular permeability? Br J Surg 75: 1273
Gosling P, Sanghera K, Dickson G (1994) Generalized vascular permeability and pulmonary function in patients following serious trauma. J Trauma 36: 477–481
Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A (1993) A novel method for measuring antioxidant capacity and its application to monitoring antioxidant status in premature neonates. Clin Sci 84: 407–412
Gosling P, Lawson N, Taylor AJ (1986) Limitations in the immunoturbidimetry of urinary albumin. Clin Chem 32:1240
Watts GF, Morris RW, Khan K, Polak A (1988) Urinary albumin excretion in healthy adult subjects: reference values and some factors affecting their interpretation. Clin Chem Acta 172:191–198
Dinarello CA, Gelfand JA, Wolff SM (1993) Anticytokine strategies in the treatment of systemic inflammatory response syndrome. JAMA 63:1829–1835
Mandell GL (1988) ARDS, neutrophils and pentoxifylline. Am Rev Respir Dis 138:1103–1105
Repine JE, Beehler CJ (1991) Neutrophils and adult respiratory distress syndrome: two interlocking perspectives in 1991. Am J Respir Dis 144: 251–2522
Rackow EC, Astiz ME (1991) Pathophysiology and treatment of septic shock. JAMA 266: 548–554
Glauser MP, Zanetti G, Baumgartner JD, Cohen J (1991) Septic shock; pathogenesis. Lancet 338: 732–736
Welbourn CSB, Young Y (1992) Endotoxin, septic shock, and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br J Surg 79: 998–1003
Cotgreave IA, Moldeus P (1987) Lung protection by thiol-containing antioxidants. Bull Eur Physiopathol Respir 23: 275–277
Aruoma OI, Halliwell B, Hoey BM, Butler J (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radie Biol Med 6: 593–597
Laurent T, Marker M, Feihl F, Schaller M-D, Perret C (1996) Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine. Chest 109:163–166
Bakker J, Zhang H, Depierreux M, Van Asbeck S, Vincent J-L (1994) Effects of N-acetylcysteine in endotoxic shock. J Crit Care 9: 236–243
Peake SL, Moran JL, Leppard PI (1996) N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 24:1302–1310
Koch T, Heller S, Heißler S, Breil I, Scheifer HG, Von Ackern K, Neuhof H (1996) Effects of N-acetylcysteine on bacterial clearance. Eur Clin Invest 26: 884–892
Peristeris P, Clark BD, Gatti S, Faggioni R, Mantovani A, Mengozzi M, Orencole SF, Sironi M, Ghezzi P (1992) N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol 140: 390–399
Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent JL (1994) Protective effects of N-acetylcysteine in endotoxemia. Am J Physiol 266: H1746–1754
Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR (1995) Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 23: 646–651
Moldeus P, Cotgreave IA (1994) N-Acetylcysteine. Methods Enzymol 482–492
Pesanti EL, Nugent KM (1985) Modulation of pulmonary clearance of bacteria by antioxidants. Infect Immun 48: 57–61
Klebanoff SJ (1980) Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 93: 480–489
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Molnar, Z., MacKinnon, K.L., Shearer, E. et al. The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients. Intensive Care Med 24, 230–235 (1998). https://doi.org/10.1007/s001340050555
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001340050555